Medtronic said Monday that the purchase includes potential post-acquisition payments. Contego, a medical-technology company based in Galway, Ireland, expects the transaction to close in the third quarter of Medtronic’s 2027 fiscal year, which began April 25.
The companies had an existing U.S. commercial arrangement: Medtronic announced an exclusive U.S. distribution agreement with Contego in January 2025.

Comments (0)
No comments yet. Be the first!